Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Proliverenol Supplementation on Liver Function in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)

NCT06127225 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.

NCT NCT06127225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06127225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Proliverenol Supplementation on Liver Function in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
Lead sponsor
Dexa Medica Group
Phase
Phase 2
Overall status
Completed
Start date
April 28, 2023
Completion date
August 28, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver disease (nafld)